TC OT 39

• CAT Number: I010993
• CAS Number: 479232-57-0
• Molecular Formula: C32H40N8O2S
• Molecular Weight: 600.79
• Purity: ≥95%
• Synonyms: (2S)-N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-2-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)thioxomethyl]-1-pyrrolidinecarboxamide
• Target: Oxytocin Receptor
• Solubility: Soluble to 100 mM in 1eq. HCl and to 100 mM in DMSO
• Storage: Store at -20C
• IUPAC Name: (2S)-2-(4-methyl-1,4-diazepane-1-carbothioyl)-N-[[2-methyl-4-(1-methyl-2,4-dihydropyrazolo[4,3-c][1,5]benzodiazepine-5-carbonyl)phenyl]methyl]pyrrolidine-1-carboxamide
• InChI: InChI=1S/C32H40N8O2S/c1-22-18-23(30(41)40-21-25-20-34-37(3)29(25)35-26-8-4-5-9-27(26)40)11-12-24(22)19-33-32(42)39-15-6-10-28(39)31(43)38-14-7-13-36(2)16-17-38/h4-5,8-9,11-12,18,20,28,34H,6-7,10,13-17,19,21H2,1-3H3,(H,33,42)/t28-/m0/s1
• InChIKey: FVJXDXYJKFLROM-NDEPHWFRSA-N
• SMILES: CC1=C(C=CC(=C1)C(=O)N2CC3=CNN(C3=NC4=CC=CC=C42)C)CNC(=O)N5CCCC5C(=S)N6CCCN(CC6)C

TC OT 39 (Cat No.: I010993) is a small-molecule inhibitor studied for its role in modulating specific cellular pathways, particularly in cancer and inflammatory disease research. While its precise target remains under investigation, it is believed to interfere with signaling mechanisms involved in cell proliferation, survival, and immune responses. TC OT 39 has potential therapeutic implications in oncology and immunology, making it a valuable tool in drug discovery. Further studies are needed to elucidate its mechanism of action and potential clinical applications.